Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
29 studies found for:    Open Studies | "Arthritis, Juvenile Rheumatoid"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Arthritis, Juvenile Rheumatoid"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis
Condition: Arthritis, Juvenile Rheumatoid
Intervention:
2 Not yet recruiting Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Biological: Blood sample
3 Recruiting Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
Condition: Juvenile Idiopathic Arthritis
Intervention:
4 Recruiting Massage Therapy in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Other: Massage therapy;   Other: Standard care
5 Recruiting Oxidation Rates of the Different Substrates During Exercise in Children and Adolescents With Juvenile Idiopathic Arthritis. Case-control Study and Cases Treated / Cases Not Treated With Anti-TNFα
Condition: Juvenile Idiopathic Arthritis
Intervention: Other: anti-TNFα
6 Recruiting An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
7 Recruiting Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tofacitinib
8 Recruiting Biomarkers in Idiopathic Juvenile Arthritis
Condition: Idiopathic Juvenile Arthritis
Intervention: Other: blood sample for identifying biomarkers
9 Recruiting A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tocilizumab
10 Recruiting Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tocilizumab
11 Recruiting A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tocilizumab
12 Recruiting An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Sarilumab SAR153191 (REGN88)
13 Recruiting Prediction of Temporomandibular Involvement in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis;   Temporomandibular Arthritis
Intervention:
14 Not yet recruiting Treatment Tapering in JIA With Inactive Disease
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: etanercept;   Drug: adalimumab;   Drug: Abatacept;   Drug: Tocilizumab
15 Recruiting Therapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthritis ?
Condition: Juvenile Idiopathic Arthritis
Intervention:
16 Recruiting Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference
Condition: Juvenile Idiopathic Arthritis
Intervention:
17 Not yet recruiting Jointly Managing JIA Online: An Internet-based Psycho-educational Game for Children With JIA and Their Parents
Condition: Juvenile Idiopathic Arthritis
Interventions: Behavioral: Game;   Other: Usual Care
18 Recruiting Efficacy Study Of Tofacitinib In Pediatric JIA Population
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: CP-690,550 (tofacitinib);   Other: placebo
19 Recruiting ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab
Condition: Systemic Juvenile Idiopathic Arthritis (SJIA)
Intervention: Drug: ACZ885 150 mg (Canakinumab)
20 Recruiting Cellular and Molecular Adaptations to Exercise-induced Inflammatory Response in Children With Autoimmune Diseases
Condition: Juvenile Idiopathic Arthritis
Intervention: Procedure: Controlled physical activity

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.